Global Navigation
Pharmaceutical
Industry News
-
AZ’s UK research job losses ‘bad news’ for country’s industry say unions
GMB and Unite say 350 job cuts in R&D at Chesire facility will damage UK industry, although ABPI remains optimistic
-
Victoza drives Novo Nordisk growth in 2011
Diabetes portfolio encourages 12 per cent increase in revenues for Denmark-based firm
-
Merck returns to profit in Q4
Gains in diabetes division, but generics pose threat for 2012
-
Mitchell Gold steps down as CEO and president of Dendreon
Former Savient CEO and Lilly senior VP John Johnson replaces Gold who remains at Dendreon as executive chair
-
Caudex Medical makes senior hires
Appoints Andy Bowman and Gary Burd
Company profiles...
Most Popular
Pharmaceutical
Industry Features
-
Major pharma deals during 2011
Deal watch: A look at the biggest mergers and acquisitions from 2011, including Sanofi's purchase of Genzyme and J&J taking over Synthes
-
Country Report: The healthcare market in Spain
Currently facing a major financial crisis, Spain's healthcare system is overstretched with autonomous regions owing millions of Euros to suppliers such as the pharma industry
-
Impact of cardiovascular events on diabetes treatment pipeline
Therapies are facing greater scrutiny to ensure they do not carry increased risk of cardiovascular side effects
-
Current and future challenges for market access in the UK
A survey of pharma companies shows they are hiring expert help to cope with the problems of an increasingly fragmented market in the UK
-
Become ‘patient intelligent’ to cure treatment aversion
Patients seldom refuse therapy outright, but often show a reluctance to comply. Understanding the reasons for this is the first step to improving their treatment
